翔宇医疗：研发销售投入加大，2024H1净利润短期承压
Xiangyu Medical(688626) 华安证券·2024-09-03 05:30翔宇医疗（ [Table_StockNameRptType] 688626） 公司点评 研发销售投入加大，2024H1 净利润短期承压 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...